about
Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnosticsMicroRNA signatures differentiate preserved from reduced ejection fraction heart failureClinician-identified problems and solutions for delayed diagnosis in primary care: a PRIORITIZE studyIdentification of priorities for improvement of medication safety in primary care: a PRIORITIZE study.The St Vincent's potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care.Life expectancy for community-based patients with heart failure from time of diagnosis.Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community - A mixed-methods evaluation.The practice gap in heart failure-the elephant in the room.Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.Use of an admission early warning score to predict patient morbidity and mortality and treatment success.Managing immune diseases in the smartphone era: how have apps impacted disease management and their future?B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and management.A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program.Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure.A prolactinoma masked by a herbal remedyCold-hearted--the electrocardiogram in hypothermiaDeficiencies in the recognition & treatment of acute illness by traineesImportance of risk factor management in diabetic patients and reduction in Stage B heart failure
P50
Q27015261-A9F8BA9B-28C0-4299-800C-78E9ACC6E6A3Q35565357-AEF43DB2-B04B-42C2-A8C5-549F3697D1A1Q36129169-4F1E7599-E93C-449F-B90B-8018AFF31DAEQ36194472-E9C7C213-0FA0-4CC9-9F6D-CAC6FFA63D3FQ38237578-D104393B-5AD9-4591-8C45-2944CDF40641Q38281239-90FA3BC9-D8E1-4D53-BE88-A5AFA13FCC7AQ38448978-7281C390-F455-4D17-9CF0-CAF34DA9DD95Q38643988-7063F839-6CF6-4570-8B14-CFF5DFBFFCFCQ38693716-E494FC29-C83A-4C02-AF00-176B2B78C587Q40809782-F662584E-4A36-4639-BC57-6DA5AEBD4D4CQ44573040-CF6F5AAC-7B6D-468F-8C1B-7024020014D4Q46021470-61917226-14A9-43BA-B4D1-964941CBA79AQ47785292-CEE41390-1AF0-4EF9-9F37-A6430346EE27Q48096616-151511A4-2607-4FD7-BCBB-FC9CDD1D1BB8Q49487884-A279696B-6BA8-44BF-8379-715E4935764BQ51329353-6F1E5614-6A17-4798-90E1-DADC183F8D4AQ52141958-0B33E5CC-23F3-4D66-8D25-C37870F17230Q79770584-E34B0306-422B-4A29-BE9A-B19BFCBF8D08Q81735612-05E1022E-5827-45E6-B42C-110D2CB2EBCCQ82627557-1143D708-857C-4DF6-8344-091F77DA2294Q85345422-4A8F5978-4491-4A5C-AE00-83ED53C8D8BB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joseph Gallagher
@ast
Joseph Gallagher
@en
Joseph Gallagher
@es
Joseph Gallagher
@nl
type
label
Joseph Gallagher
@ast
Joseph Gallagher
@en
Joseph Gallagher
@es
Joseph Gallagher
@nl
prefLabel
Joseph Gallagher
@ast
Joseph Gallagher
@en
Joseph Gallagher
@es
Joseph Gallagher
@nl
P106
P1153
25926470400
P21
P31
P496
0000-0002-5564-2890